Retatrutide (research phase) Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors
In both studies, tesamorelin-treated patients completing the 26-week treatment period were re-randomized to blinded therapy with either daily placebo or 2 mg tesamorelin for an additional 26-week treatment period (Extension Phase) in order to assess maintenance of VAT reduction and to gather long-term safety data

PLEASE SELECT THE GLP-1 PRODUCT FROM OUR OPTIONS AVAILABLE: (BRANDNAME MEDICATIONS ARE LSITED AS EQUIVALENT NOTES TO ASSIST)(Required)Semaglutide 1mg/Glycine5 (equiv Ozempic/Wegovy 0.25mg)Semaglutide 1mg/Glycine5 (equiv Ozempic/Wegovy 0.5mg)Semaglutide 1mg/Glycine5 (equiv Ozempic/Wegovy 1.0mg)Semaglutide 2.4mg/Glycine5 (equiv Ozempic/Wegovy 2.0mg)Tirzepatide 12.5mg/Glycine 5mg (equiv Moujaro/Zepbound 2.5mg)Tirzepatide 12.5mg/Glycine 5mg (equiv Moujaro/Zepbound 5mg)Tirzepatide 25mg/Glycine 5mg (equiv Moujaro/Zepbound 7.5mg)Tirzepatide 25mg/Glycine 5mg (equiv Moujaro/Zepbound 10mg)Tirzepatide 25mg/Glycine 5mg (equiv Moujaro/Zepbound 12.5mg)Tirzepatide 25mg/Glycine 5mg (equiv Moujaro/Zepbound 25mg)DELIVERY OF YOUR COMPOUNDED GLP-1 PRESCRIPTION:(Required) I will be picking up my prescription at Haydens Pharmacy, 505 North Fourth Street, Youngwood, PA

PCOS is considered the major cause of anovulatory infertility 4 , and is linked to other manifestations caused by androgen excess, such as hirsutism and acne
Reduces Water RetentionSupports a leaner, more defined appearance by minimizing excess water in the body